September 2013 pulmonary journal club: riociguat; pay the doctor

September 2013 pulmonary journal club: riociguat; pay the doctor

No abstract available. Article truncated at 150 words. Three articles appeared within the past month describing clinical trials with riociguat, a new therapy for pulmonary arterial hypertension (PAH). Riociguat is a soluble guanylate cyclase stimulator. Guanylate cyclase is the enzyme that is stimul...

Full description

Bibliographic Details
Main Author:	Robbins RA
Format:	Article
Language:	English
Published:	Arizona Thoracic Society 2013-09-01
Series:	Southwest Journal of Pulmonary and Critical Care
Subjects:	riociguat pulmonary hypertension thromboembolic pulmonary hypertension left ventricular dysfunction guanylate cyclase pay for performance affordable care act Obamacare Veterans Administration outcomes ACA treatment
Online Access:	http://www.swjpcc.com/pulmonary-journal-club/2013/9/16/september-2013-pulmonary-journal-club-riociguat-pay-the-doct.html

Similar Items

Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
by: N. H. Kim
Published: (2010-03-01)

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
by: S. E. Gratsianskaya, et al.
Published: (2020-10-01)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
by: Alberto M. Marra, et al.
Published: (2018-12-01)

Identifying Barriers to Enrollment of Diverse Populations in Arizona Following the Initial Open Enrollment Period of the Affordable Care Act
by: Moseley, Joseph
Published: (2017)

Treatment of patients with chronic thromboembolic pulmonary hypertension: focus on riociguat
by: Smith ZR, et al.
Published: (2016-06-01)

Trump proposes initial healthcare agenda
by: Robbins RA
Published: (2016-11-01)

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences
by: Asger Andersen, et al.
Published: (2017-01-01)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
by: Vallerie V. McLaughlin, et al.
Published: (2017-12-01)

National health expenditures: the past, present, future and solutions
by: Robbins RA
Published: (2015-10-01)

Health System Reform in the United States
by: John E McDonough
Published: (2014-01-01)

Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study
by: Tatsuo Aoki, et al.
Published: (2020-08-01)

July 2013 pulmonary journal club
by: Mathew M
Published: (2013-07-01)

Modern view on the place of riociguat in the treatment of pulmonary hypertension
by: Z S Valieva, et al.
Published: (2018-04-01)

Modern view on the place of riociguat in the treatment of pulmonary hypertension
by: Z.S. Valieva, et al.
Published: (2018-04-01)

Limited choice of healthcare insurers in some parts of the southwest
by: Robbins RA
Published: (2017-06-01)

Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
by: M. A. Simakova, et al.
Published: (2020-05-01)

Does the Accountable Care Act Aim to Promote Quality, Health, and Control Costs or Has It Missed the Mark? ;Comment on “Health System Reform in the United States”
by: Carol Molinari
Published: (2014-02-01)

Healthcare.gov shares personal data with third parties
by: Robbins RA
Published: (2015-01-01)

Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
by: E. V. Filippov
Published: (2020-12-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
by: N. V. Marukyan, et al.
Published: (2021-05-01)

Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
by: Lian TY, et al.
Published: (2017-04-01)

Experience of the management of patients with pulmonary hypertension in the Republic of Karelia
by: Vadim A Ryabkov, et al.
Published: (2019-09-01)

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry
by: Pavel Jansa, et al.
Published: (2021-06-01)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Chronic thromboembolic pulmonary hypertension
by: Eckhard Mayer, et al.
Published: (2014-01-01)

The evil that men do-an open letter to President Obama
by: Robbins RA
Published: (2016-05-01)

Evolution of Physician-Centric Business Models Under Patient Protection and Affordable Care Act
by: Nix, Tanya J.
Published: (2014)

Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy
by: H. A. Ghofrani, et al.
Published: (2009-03-01)

Identifying the insured and uninsured in rural America: an empirical discriminant analysis
by: Promise Tewogbola, et al.
Published: (2021-05-01)

Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells
by: Julie Dillard, et al.
Published: (2020-09-01)

A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy
by: Ali Ataya, et al.
Published: (2016-12-01)

Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: N. A. Tsareva, et al.
Published: (2016-12-01)

Who will benefit and who will lose from Obamacare?
by: Mathew M, et al.
Published: (2013-08-01)

Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
by: I E Chazova, et al.
Published: (2019-09-01)

Insurance Status and healthcare disparity in patients with Hodgkin’s lymphoma before and after the Affordable Care Act: a SEER database study
by: Binbin Zheng-Lin, et al.
Published: (2019-08-01)

Tea Party Health Narratives and Belief Polarization: the Journey to Killing Grandma
by: Kristin Haltinner, et al.
Published: (2017-11-01)

CHRONIC POST-THROMBOEMBOLIC PULMONARY HYPERTENSION DEVELOPMENT IN A PATIENT WITH HEREDITARY THROMBOPHILIA: A CASE REPORT
by: A. A. Klimenko, et al.
Published: (2017-01-01)

The Realization of Impoliteness in Arguments between the Democrats and Republicans over the Government Shutdown Issue in the US
by: Minoo Alemi, et al.
Published: (2019-12-01)

Senate Republican leadership releases revised ACA repeal and replace bill
by: Moore NS
Published: (2017-07-01)

Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
by: Munish Sharma, et al.
Published: (2021-04-01)

The Affordable Care Act and the Diffusion of Policy Feedback: The Case of Medicaid Work Requirements
by: Richard C. Fording, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_cr1oaguignsnke3fqm1mj2fj8p